Rivastigmine Tartrate rivastigmine 6 MG Oral Capsule
1 INDICATIONS & USAGE Rivastigmine tartrate capsules, are an acetylcholinesterase inhibitor indicated for treatment of: Mild to moderate dementia of the Alzheimer’s type (1.1) Mild to moderate dementia associated with Parkinson’s disease (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type. 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia associated with Parkinson’s disease.
Alembic Pharmaceuticals Limited
CAPSULE ORANGE B 796
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIVASTIGMINE TARTRATE capsules USP
RIVASTIGMINE TARTRATE capsules equivalent to 1.5 mg, 3 mg, 4.5 mg, or 6 mg of rivastigmine base are available as follows: 1.5 mg capsule – Pale yellow opaque / pale yellow opaque, size ‘2’ hard gelatin capsules radially imprinted with ‘A’ on cap and ‘116’ on body with black ink, filled with white to off - white free flowing powder. NDC 46708-063-30 Bottle of 30 capsules NDC 46708-063-60 Bottle of 60 capsules NDC 46708-063-71 Bottle of 500 capsules NDC 46708-063-91 Bottle of 1000 capsules NDC 46708-063-10 Unit Dose capsules of 100 (Blisters of 10) 3 mg capsule – orange opaque / orange opaque, size ‘2’ hard gelatin capsules radially imprinted with ‘A’ on cap and ‘117’ on body with black ink, filled with white to off - white free flowing powder. NDC 46708-064-30 Bottle of 30 capsules NDC 46708-064-60 Bottle of 60 capsules NDC 46708-064-71 Bottle of 500 capsules NDC 46708-064-91 Bottle of 1000 capsules NDC 46708-064-10 Unit Dose capsules of 100 (Blisters of 10) 4.5 mg capsule – coral red opaque / coral red opaque, size ‘2’ hard gelatin capsules radially imprinted with ‘A’ on cap and ‘118’ on body with black ink, filled with white to off - white free flowing powder. NDC 46708-065-30 Bottle of 30 capsules NDC 46708-065-60 Bottle of 60 capsules NDC 46708-065-71 Bottle of 500 capsules NDC 46708-065-91 Bottle of 1000 capsules NDC 46708-065-10 Unit Dose capsules of 100 (Blisters of 10) 6 mg capsule – orange opaque / coral red opaque, size ‘2’ hard gelatin capsules radially imprinted with ‘A’ on cap and ‘119’ on body with black ink, filled with white to off - white free flowing powder. NDC 46708-066-30 Bottle of 30 capsules NDC 46708-066-60 Bottle of 60 capsules NDC 46708-066-71 Bottle of 500 capsules NDC 46708-066-91 Bottle of 1000 capsules NDC 46708-066-10 Unit Dose capsules of 100 (Blisters of 10) Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Store in a tight container.
More pills like CAPSULE B 796